Heltovics G., Ötvös Zs., Filipcsei G., Darvas F.
NanGenex Inc., HU
Keywords: drug nanoparticles, enhanced bioavailability, increase solubility
In the presentation we will discuss the perspectives and pharmacokinetic benefits of the nanosized active molecules over the parent active molecules. The bioavailability of reference and nanosized drug was determined after oral administration (30 mg/kg) in fasted state at Sprague-Dawley rats using international standard protocols. Nanosized drug had an AUC15-360 min value of 6412 µg∙min/ml while this value after reference treatment was 940.1 µg∙min/ml. The ratio of the two AUC values (AUC15-360 min (nanosized) / AUC15-360 min (reference)) was 6.82. Work was supported by the Hungarian Grant KMOP-1.1.1-09/1-2009-0025.
Journal: TechConnect Briefs
Volume: 3, Nanotechnology 2010: Bio Sensors, Instruments, Medical, Environment and Energy
Published: June 21, 2010
Pages: 338 - 341
Industry sector: Medical & Biotech
Topics: Biomaterials, Materials for Drug & Gene Delivery
ISBN: 978-1-4398-3415-2